Get started
Ono Pharmaceutical Co. Ltd. Registered Shares o.N.OO

Ono Pharmaceutical Co. Ltd. Registered Shares o.N.

10.100EURD
−0.300−2.88%
As of today at 06:11 GMT
EUR
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Seasonals

ON4 chart


Full chart

ON4 upcoming earnings


Next report date
May 8
Report period
Q4 2024
EPS estimate
0.14 EUR
Revenue estimate
‪749.13 M‬ EUR

Key stats


Market capitalization
‪4.91 B‬ EUR
Dividend yield (indicated)
4.72%
Price to earnings Ratio (TTM)
10.716
Basic EPS (TTM)
0.968 EUR
Net income (FY)
‪783.64 M‬ EUR
Revenue (FY)
‪3.08 B‬ EUR
Shares float
‪328.10 M‬
Beta (1Y)
0.39

Employees


Employees (FY)
‪3.85 K‬
Change (1Y)
+92 +2.45%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About ONO PHARMACEUTICAL CO


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Gyo Sagara
Website
ono.co.jp
Headquarters
Osaka
Founded
1947
ISIN
JP3197600004
FIGI
BBG000C4Q9Y2
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Financials


Performance
‪10%‬
‪15%‬
‪20%‬
‪25%‬
‪30%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪220.00 M‬‬
‪‪440.00 M‬‬
‪‪660.00 M‬‬
‪‪880.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−400.00 M‬‬
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 8, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.08‬
‪0.16‬
‪0.24‬
‪0.32‬
Actual
Estimate

ON4 news



No news here

Looks like there's nothing to report right now

Reload

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stocks are traded under the ticker ON4.
We've gathered analysts' opinions on Ono Pharmaceutical Co. Ltd. Registered Shares o.N. future price: according to them, ON4 price has a max estimate of 15.42 EUR and a min estimate of 8.63 EUR. Watch ON4 chart and read a more detailed Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock forecast: see what analysts think of Ono Pharmaceutical Co. Ltd. Registered Shares o.N. and suggest that you do with its stocks.
ON4 reached its all-time high on Jul 14, 2022 with the price of 27.600 EUR, and its all-time low was 9.350 EUR and was reached on Feb 3, 2025. View more price dynamics on ON4 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financials in yearly and quarterly reports right on TradingView.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
ON4 earnings for the last quarter are 0.20 EUR per share, whereas the estimation was 0.26 EUR resulting in a −23.96% surprise. The estimated earnings for the next quarter are 0.14 EUR per share. See more details about Ono Pharmaceutical Co. Ltd. Registered Shares o.N. earnings.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. revenue for the last quarter amounts to ‪824.62 M‬ EUR, despite the estimated figure of ‪805.48 M‬ EUR. In the next quarter, revenue is expected to reach ‪749.13 M‬ EUR.
ON4 net income for the last quarter is ‪91.78 M‬ EUR, while the quarter before that showed ‪105.35 M‬ EUR of net income which accounts for −12.88% change. Track more Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financial stats to get the full picture.
Ono Pharmaceutical Co. Ltd. Registered Shares o.N. dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 24, 2025, the company has ‪3.85 K‬ employees. See our rating of the largest employees — is Ono Pharmaceutical Co. Ltd. Registered Shares o.N. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ono Pharmaceutical Co. Ltd. Registered Shares o.N. EBITDA is ‪690.32 M‬ EUR, and current EBITDA margin is 36.15%. See more stats in Ono Pharmaceutical Co. Ltd. Registered Shares o.N. financial statements.
Like other stocks, ON4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ono Pharmaceutical Co. Ltd. Registered Shares o.N. stock right from TradingView charts — choose your broker and connect to your account.